Concepedia

Publication | Open Access

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway

DOIFull Paper Access

17

Citations

43

References

2021

Year

Jun-Qing Jin, Jeong‐Sun Han, Jeonghoon Ha, Han-Sang Baek, Dong‐Jun Lim
Endocrinology and Metabolism

Abstract

LGZ inhibits TGF-β1-induced EMT, migration, and invasion through the p38 MAPK signaling pathway in a PPAR-γ-dependent manner in PTC cells.

References

YearCitations

Page 1